Home
>
National Drug Code (NDC)
>
Tradjenta
Tradjenta - 0597-0140-90 - (linagliptin)
Drug Information of Tradjenta
| Product NDC: | 0597-0140 |
| Proprietary Name: | Tradjenta |
| Non Proprietary Name: | linagliptin |
| Active Ingredient(s): | 5 mg/1 & nbsp; linagliptin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tradjenta
| Product NDC: | 0597-0140 |
| Labeler Name: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201280 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110509 |
Package Information of Tradjenta
| Package NDC: | 0597-0140-90 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0597-0140-90) |
NDC Information of Tradjenta
| NDC Code | 0597-0140-90 |
| Proprietary Name | Tradjenta |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0597-0140-90) |
| Product NDC | 0597-0140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | linagliptin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110509 |
| Marketing Category Name | NDA |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | LINAGLIPTIN |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] |
